bioRxivImmunologyPreprint
Inflammatory endothelial cells promote infiltration of antigen-licensed cytotoxic T cells in malignant gliomas after irradiation
Clara TejidoiD, Niklas GraßliD, Nirmeen ElmadanyiD, Jakob Rosenbauer, Zaira SeferbekovaiD, Khwab SanghviiD, Dennis Alexander AgardyiD, Ralph Sinn, Theresa BunseiD, Anna MathioudakiiD, Kristine JähneiD, Jana K. SonneriD, Michael O. BreckwoldtiD, Abigail Kora SuwalaiD, Moritz GerstungiD, Felix SahmiD, Lukas BunseiD, Michael PlatteniD, Katharina SahmiD
- Citations
- 0
Abstract
Insufficient T cell infiltration into malignant gliomas fundamentally limits the efficacy of adoptive T cell therapy. Here we show that fractionated irradiation overcomes this barrier by reprogramming the tumor endothelium towards an immune-recruiting interface. Using complementary murine glioma models combined with adoptive T cell transfer, antigen-specific vaccination, and single-cell transcriptomic and T cell receptor profiling, we demonstrate that irradiation enhances the accumulation, clonal expansion, and effector differentiation of tumor-specific CD8+ T cells. Irradiated tumors showed increased T cell receptor clonality and local enrichment of proliferative effector CD8 T cells with enhanced cytotoxic, interferon-responsive, and oxidative metabolic programs. Mechanistically, irradiation triggers a conserved interferon-driven endothelial program marked by antigen presentation and upregulation of adhesion molecules, including ICAM-1 and VCAM-1. This radiation-induced endothelial activation program preferentially seen in inflammatory endothelial subsets was conserved in human glioblastoma and linked to T cell recruitment and maintenance of activated CD8 T cell states. Functionally, irradiation synergized with adoptive T cell transfer and antigen-specific vaccination to promote glioma-specific T cell accumulation and effector differentiation, improving tumor control and survival. Together, these findings identify radiation-induced endothelial activation as a key regulator of T cell trafficking across the brain tumor vasculature highlighting the vascular niche as a critical determinant of immunotherapy efficacy and a rational target for combination strategies in glioblastoma.
- organism: mouse
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- T-Cell-Mediated Killing in Glioblastoma Organoids induced by Adenoviral Delivery of the CIITA Transgene
I. Salvato, E. Klein, … S. P. Niclou·bioRxiv·Jan 22, 2024
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma
L. van Hooren, A. Vaccaro, … A. Dimberg·bioRxiv·Jan 5, 2021
- Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
Amy J. Wisdom, Zachary J. Rogers, … Stefani Spranger·bioRxiv·Sep 22, 2026
- Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity
Taral R. Lunavat, Lisa Nieland, … Koen Breyne·bioRxiv·Feb 3, 2025
- IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models
K. Singh, K. M. Hotchkiss, … P. E. Fecci·bioRxiv·Apr 1, 2024
- Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity
Emily E Steffke, Laila Latifi, … Masaki Terabe·bioRxiv·Jun 20, 2026